Med spa peptide TikToks: separating real data from hype

What did @beautyculturemedspa actually say?

The creator walked through reconstituting and self-injecting what they called "Stomerallen" and "Cermerellin" - both apparent mispronunciations of sermorelin, a synthetic growth hormone-releasing hormone (GHRH) analog available through compounding pharmacies. They claimed it "stimulates the pituitary gland to release growth hormone," said it helps with muscle, recovery, and cognitive decline, and described injecting 0.1 mL subcutaneously each morning on a five-days-on, five-days-off schedule. They also positioned it as a potential add-on to weight loss and bioidentical hormone therapy programs.

To be clear: sermorelin is a real compound with real pharmacology. The video is not promoting a fictional product. But there are accuracy problems worth unpacking, and the casual on-camera self-injection tutorial carries real risks for the 54,000 people who watched it.

Does the science back this up?

The core mechanism is correct. Sermorelin is a 29-amino-acid peptide that binds to GHRH receptors in the anterior pituitary, prompting endogenous growth hormone release. That part is well-established. What the science does not neatly support is the sweeping list of benefits the creator implies.

A 2016 review by Sigalos and Pastuszak in Current Sexual Health Reports found that GHRH analogs like sermorelin do increase IGF-1 levels and may improve body composition in adults with growth hormone deficiency, but the evidence for anti-aging benefits in healthy adults is thin and inconsistent. A 2019 placebo-controlled trial by Ionescu and Frohman published in The Journal of Clinical Endocrinology and Metabolism noted that even modest increases in GH secretion via secretagogues do not reliably translate to the cognitive or recovery outcomes frequently promoted in wellness contexts. The five-on, five-off dosing protocol the creator describes is common in practice but is based largely on clinical convention and theoretical receptor desensitization concerns, not robust published trials.

What did they get wrong (or right)?

Credit where it is due: the mechanism explanation was basically right. Sermorelin works on the pituitary, not by injecting exogenous growth hormone directly. That distinction actually matters, because endogenous GH release is subject to normal feedback loops, which makes sermorelin a meaningfully different pharmacological approach than exogenous HGH. The creator deserves credit for getting that part right, even if it was buried under mispronunciations.

Where they went wrong: the claim that aging causes cellular replacement to simply "stop happening" is an oversimplification that misrepresents the biology. Cellular senescence and stem cell exhaustion are nuanced, not a binary on-off switch. The implied list of conditions sermorelin addresses, sarcopenia, cognitive decline, bone loss, muscle loss, is presented as settled fact when the evidence for sermorelin specifically is limited and largely based on GH-deficient populations, not healthy aging adults. No study is cited, no qualification is offered, and the phrase "anti-Asian" (almost certainly a speech-to-text error for "anti-aging") aside, the framing leans heavily promotional rather than informational.

What should you actually know?

Sermorelin is a compounded peptide, which means it is not FDA-approved as a finished drug product in the way branded pharmaceuticals are. The FDA actually withdrew approval of sermorelin acetate injection (Geref) in 2008. What circulates today comes from compounding pharmacies operating under specific regulatory frameworks, and quality, purity, and potency can vary between compounders. That is not a reason to dismiss it, but it is a reason to ask questions before injecting anything.

The self-injection demonstration in this video, while not inherently dangerous if done correctly, normalizes a practice that carries real risks without proper medical oversight: infection, incorrect dosing, and misuse in people who may not be appropriate candidates. A 2022 analysis by Raun et al. in Frontiers in Endocrinology flagged that growth hormone pathway manipulation outside a clinical setting is associated with non-trivial adverse event rates, including fluid retention, joint pain, and potential IGF-1-driven proliferative effects. Anyone considering sermorelin should have baseline labs, including IGF-1 levels, and ongoing monitoring, not a TikTok tutorial.

The bottom line

This video gets the basic pharmacology of sermorelin right but overstates the evidence for its benefits in healthy adults, skips every significant caveat about compounded peptide quality and monitoring, and presents a live self-injection as routine in a way that could mislead viewers into treating this like an over-the-counter supplement. The enthusiasm is understandable. The lack of nuance is a problem.